Engineered flagellin-based adjuvant boosts mucosal immunity in recombinant RSV vaccine. Ye G, Qu C, Liao Z, Wu R, et al. Vaccine 2026;73:128190.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ye G, Qu C, Liao Z, Wu R, et al. Engineered flagellin-based adjuvant boosts mucosal immunity in recombinant RSV vaccine. Vaccine 2026;73:128190.
PMID: 41485249